Effect of L-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials

Nazarian, Behzad and Fazeli Moghadam, Ezatollah and Asbaghi, Omid and Zeinali Khosroshahi, Mohammad and Choghakhori, Razieh and Abbasnezhad, Amir (2019) Effect of L-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine.

[img]
Preview
Text
1-s2.0-S0965229919314347-main.pdf

Download (977kB) | Preview

Abstract

Objectives: Wecarriedoutasystematicreviewandmeta-analysis ofrandomizedcontrolled trials(RCTs)toassess the effect of L-arginine on inflammatory biomarkers including C-reactive protein (CRP), interleukin-6 (IL-6) and TNFα. Methods: A systematic search was carried out in PubMed, Embase, Scopus, Cochrane library databases and ISI web of sciences to retrieve the RCTs which examined the effect of L-arginine supplementation on inflammatory biomarkers up to October 2019, with no language and time restriction. Meta-analysis was performed using a random effects model, and I2 index was used to evaluate the heterogeneity. Results: Search yielded 2452 publications. Eleven RCTs were eligible. Results indicated that L-arginine supplementation had no significant effect on inflammatory biomarkers including CRP, IL-6 and TNFα. However, when subgroup analysis was performed, we found that L-arginine supplementation increased CRP levels in subjects with ages>60 years old, participants with baseline circulating CRP levels>3mg/dl, patients with cancer and when used in enteral formula. Conclusion: Results of the present meta-analysis indicated that L-arginine supplementation increased the circulating concentrations of CRP in subjects with ages>60 years old, subjects with higher levels of CRP, patients with cancer and when used in enteral formula. Therefore, L-arginine should be used with caution in these subjects. However, further well designed, large-scale studies are needed.

Item Type: Article
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: samira sepahvandy
Date Deposited: 12 May 2020 04:15
Last Modified: 12 May 2020 04:15
URI: http://eprints.lums.ac.ir/id/eprint/2051

Actions (login required)

View Item View Item